Vasodilator and inotropic therapy for severe chronic heart failure: Passion and skepticism
- 1 November 1983
- journal article
- review article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 2 (5) , 841-852
- https://doi.org/10.1016/s0735-1097(83)80230-7
Abstract
No abstract availableKeywords
This publication has 128 references indexed in Scilit:
- Hemodynamic Characterization of Tolerance to Long-Term Hydralazine Therapy in Severe Chronic Heart FailureNew England Journal of Medicine, 1982
- Decreased Lymphocyte Beta-Adrenergic-Receptor Density in Patients with Heart Failure and Tolerance to the Beta-Adrenergic Agonist PirbuterolNew England Journal of Medicine, 1981
- Importance of Left Ventricular Chamber Size in Determining the Response to Hydralazine in Severe Chronic Heart FailureNew England Journal of Medicine, 1980
- Long-Term Vasodilator Therapy with Trimazosin in Chronic Cardiac FailureNew England Journal of Medicine, 1980
- Treatment of Chronic Congestive Heart Failure with Captopril, an Oral Inhibitor of Angiotensin-Converting EnzymeNew England Journal of Medicine, 1979
- Hemodynamic Assessment of AmrinoneNew England Journal of Medicine, 1978
- A New Inotropic Drug: Its Promise and a CautionNew England Journal of Medicine, 1978
- Sustained Reduction of Cardiac Impedance and Preload in Congestive Heart Failure with the Antihypertensive Vasodilator PrazosinNew England Journal of Medicine, 1977
- Oral hydralazine therapy for chronic refractory heart failure.Circulation, 1976
- Hemodynamic Effects of Orally Administered Isosorbide Dinitrate in Patients with Congestive Heart FailureCirculation, 1974